Cancer of the uterine wall, medically known as “endometrial cancer,” is the gynecological cancer most strongly associated with obesity, and obesity is found in 75% of this patient group. Most patients with uterine wall cancer present at an early stage, and the long-term oncological outcomes of these patients with surgical treatment are quite successful. However, patients' long-term survival and quality of life depend on the treatment of obesity and the related problems. There are data showing that bariatric surgery, particularly in this patient group, helps with weight loss, prevents comorbid diseases and even reduces the risk of cancer recurrence. Research has also shown that recommending a bariatric procedure to patients at an early stage increases acceptance of the treatment.

A patient who presented to the Department of Obstetrics and Gynecology at Hacettepe University Hospitals was found to have super obesity (body weight: 157 kg, BMI: 60), and an endometrial biopsy led to a diagnosis of uterine wall cancer. By the multidisciplinary decision of the Endocrinology Division of the Adult Hospital, the Gynecologic Oncology Surgery Division and the Department of General Surgery, it was decided that the best treatment for the young patient's long-term survival and quality of life would be combined robotic hysterectomy and bariatric surgery. The operation, performed simultaneously by the Gynecologic Oncology Surgery Division and the Department of General Surgery, was carried out successfully. In this operation, which is significant as a first in Turkey, the patient's anesthesia was also managed successfully by the Department of Anesthesiology and Reanimation; our patient was discharged without complications on the third day after surgery.